Call our law firm today! Consult with the partners for FREE. 800-734-9445

RGLZ Attorneys Named to the “Super Lawyers”, “Rising Stars” List for 2019

By |2019-11-07T17:39:58+00:00November 7th, 2019|Uncategorized|

Congratulations Rappaport, Glass, Levine and Zullo LLP, is proud to announce that six attorneys at the firm, in multiple practice areas, have been named to the 2019 Super Lawyers list, two of them as “Rising Stars.” The RGLZ attorneys recognized this year are: Michael Glass– Practice Areas:  Personal Injury - Medical Malpractice: Plaintiff (70%), Personal Injury - [...]

FDA orders manufacturers of surgical mesh intended to treat pelvic organ prolapse, to stop distribution immediately

By |2019-05-09T13:29:26+00:00May 7th, 2019|Defective Medical Equipment, Defective Products, Medical Malpractice, Recalls, Uncategorized|

On April 16, 2019, the FDA ordered all manufacturers of surgical mesh intended for transvaginal repair of anterior compartment prolapse (cystocele) to stop selling and distributing their products immediately. The FDA has determined that the manufacturers, Boston Scientific and Coloplast, have not demonstrated reasonable assurance of safety and effectiveness for these devices, which is the premarket standard [...]

Nursing Home Staffing Data 2018

By |2019-03-11T20:31:41+00:00March 11th, 2019|Nursing Home Injuries, Nursing Home Negligence, Uncategorized|

Long Term Care Community Coalition (LTCCC)  publishes, on a quarterly basis, information on staffing for every nursing home in the country (that is in compliance with federal staff reporting requirements). Sufficient staffing is one of the most important indicators of a nursing home’s quality and safety. Unfortunately, inadequate nursing home staffing is a widespread and persistent [...]

Recall Changes on Valsartan, Losartan and Irbesartan

By |2019-05-09T13:30:55+00:00March 1st, 2019|Failure To Diagnose, Local News, Medical Malpractice, Medical Recalls, Uncategorized|

FDA updates on angiotensin II receptor blocker (ARB) recalls including valsartan, losartan and irbesartan IMPORTANT: Medications containing only amlodipine or hydrochlorothiazide (HCTZ) are not being recalled. Manufacturers are recalling medications containing amlodipine in combination with valsartan or losartan, and medications containing hydrochlorothiazide HCTZ in combination with valsartan or losartan. […]

Mass Tort Report – RGLZ Personal Injury Law

By |2018-10-22T18:50:06+00:00April 5th, 2017|Medical Malpractice, Tort Cases, Uncategorized|

RGLZ is currently looking for cases involving the following drugs and devices: Ethicon Physiomesh, Atrium C-Qur, And Bard Ventralex Surgical Mesh Failures: There are a variety of mesh products used to surgically treat hernias and other soft-tissue defects, with doctors using these products in more than 1 million operations each year. Many of these mesh [...]

Defective St. Jude ICD / CRT-D Devices

By |2018-02-13T20:33:38+00:00November 10th, 2016|Defective Products, Medical Malpractice, Medical Recalls, Uncategorized|

Defective St. Jude ICD / CRT-D Devices St. Jude Medical Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronization Therapy Defibrillator (CRT-D) devices - Early Battery Depletion If you are a New York user of a St. Jude Implantable Cardioverter Defibrillator (ICD) or Cardiac Resynchronization Therapy Defibrillator (CRT-D), you need to be aware of a major defect [...]

Comments Off on Defective St. Jude ICD / CRT-D Devices